THE ACCEPTABILITY OF COMBINED METHADONE-NALOXONE TREATMENT: CONSUMER AND PROVIDER VIEWS ON THE POTENTIAL UTILITY OF METHADONE-NALOXONE
Gespeichert in:
SHEARER, J., ET AL., THE ACCEPTABILITY OF COMBINED METHADONE-NALOXONE TREATMENT: CONSUMER AND PROVIDER VIEWS ON THE POTENTIAL UTILITY OF METHADONE-NALOXONE. DRUG AND ALCOHOL REVIEW, Vol. 29, no. 2 (2010), p. 138-143.
Ref.
166878
Standort:
SIIS R.1025 Archivo
Palabras clave:
Actitudes usuarios, Drogas ilegales, Drogodependencias, Estudio cualitativo, Fármacos, Innovaciones, Metadona, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento médico
Actitudes usuarios, Drogas ilegales, Drogodependencias, Estudio cualitativo, Fármacos, Innovaciones, Metadona, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento médico
Ähnliche Einträge: THE ACCEPTABILITY OF COMBINED METHADONE-NALOXONE TREATMENT: CONSUMER AND PROVIDER VIEWS ON THE POTENTIAL UTILITY OF METHADONE-NALOXONE
- Opioid overdose prevention with intranasal naloxone among people who take methadone
- Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
- Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial
- SUBLINGUAL BUPRENORPHINE/NALOXONE PRECIPITATED WITHDRAWAL IN SUBJECTS MAINTAINED ON 100 MG OF DAILY METHADONE
- TIME COURSE OF NALOXONE-PRECIPITATED WITHDRAWAL AFTER ACUTE METHADONE EXPOSURE IN HUMANS
- Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program